453 related articles for article (PubMed ID: 27075473)
1. CAF cellular glycolysis: linking cancer cells with the microenvironment.
Roy A; Bera S
Tumour Biol; 2016 Jul; 37(7):8503-14. PubMed ID: 27075473
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
Yoshida GJ
J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
[TBL] [Abstract][Full Text] [Related]
4. [Even the Warburg effect can be oxidized: metabolic cooperation and tumor development].
Cordier-Bussat M; Thibert C; Sujobert P; Genestier L; Fontaine É; Billaud M
Med Sci (Paris); 2018; 34(8-9):701-708. PubMed ID: 30230466
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming of the tumour microenvironment.
Xing Y; Zhao S; Zhou BP; Mi J
FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts.
Han Y; Zhang Y; Jia T; Sun Y
Tumour Biol; 2015 Mar; 36(3):1385-94. PubMed ID: 25680413
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
Aden D; Zaheer S; Ahluwalia H; Ranga S
Cell Biol Int; 2023 May; 47(5):859-893. PubMed ID: 36871165
[TBL] [Abstract][Full Text] [Related]
8. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
Li C; Zhang G; Zhao L; Ma Z; Chen H
World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
[TBL] [Abstract][Full Text] [Related]
9. From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation.
Servais C; Erez N
J Pathol; 2013 Jan; 229(2):198-207. PubMed ID: 22996812
[TBL] [Abstract][Full Text] [Related]
10. Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities.
Ganapathy-Kanniappan S
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):212-220. PubMed ID: 28400131
[TBL] [Abstract][Full Text] [Related]
11. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
Gatenby RA; Gawlinski ET
Cancer Res; 2003 Jul; 63(14):3847-54. PubMed ID: 12873971
[TBL] [Abstract][Full Text] [Related]
12. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
13. Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types.
Gandellini P; Andriani F; Merlino G; D'Aiuto F; Roz L; Callari M
Semin Cancer Biol; 2015 Dec; 35():96-106. PubMed ID: 26320408
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblasts that restrain cancer progression: Hypotheses and perspectives.
Miyai Y; Esaki N; Takahashi M; Enomoto A
Cancer Sci; 2020 Apr; 111(4):1047-1057. PubMed ID: 32060987
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism.
Zhao H; Yang L; Baddour J; Achreja A; Bernard V; Moss T; Marini JC; Tudawe T; Seviour EG; San Lucas FA; Alvarez H; Gupta S; Maiti SN; Cooper L; Peehl D; Ram PT; Maitra A; Nagrath D
Elife; 2016 Feb; 5():e10250. PubMed ID: 26920219
[TBL] [Abstract][Full Text] [Related]
16. Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery.
Lisanti MP; Martinez-Outschoorn UE; Sotgia F
Cell Cycle; 2013 Sep; 12(17):2723-32. PubMed ID: 23860382
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer-secreted miR-155 implicates in the conversion from normal fibroblasts to cancer-associated fibroblasts.
Pang W; Su J; Wang Y; Feng H; Dai X; Yuan Y; Chen X; Yao W
Cancer Sci; 2015 Oct; 106(10):1362-9. PubMed ID: 26195069
[TBL] [Abstract][Full Text] [Related]
18. Linking metabolic reprogramming to therapy resistance in cancer.
Morandi A; Indraccolo S
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):1-6. PubMed ID: 28065746
[TBL] [Abstract][Full Text] [Related]
19. The role of mammalian sirtuins in cancer metabolism.
Sebastián C; Mostoslavsky R
Semin Cell Dev Biol; 2015 Jul; 43():33-42. PubMed ID: 26238985
[TBL] [Abstract][Full Text] [Related]
20. Metabolic crosstalk in the breast cancer microenvironment.
Dias AS; Almeida CR; Helguero LA; Duarte IF
Eur J Cancer; 2019 Nov; 121():154-171. PubMed ID: 31581056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
